(Press-News.org) When disease-resistant rice is invaded by disease-causing bacteria, a small protein produced by the bacteria betrays the invader. Upon recognizing that protein, the rice plants sense that a microbial attack is underway and are able to mount an immune response to fend off bacterial infection, reports a research team led by the University of California, Davis.
Identification of the tiny protein, called RaxX, holds promise for developing more disease-resistant crop varieties and therapeutic treatments for blocking microbial infections in both plants and animals, said the researchers, who found particular satisfaction in this discovery, two years after retracting the announcement of a similar find.
Results of the new study will be reported July 24 in Science Advances, an open-access journal published by the American Association for the Advancement of Science. The paper will then be available online from the journal at http://bit.ly/1OmytAd.
Discovery unlocks clues to disease protection:
In this new study, researchers discovered that the RaxX protein was present in at least eight species of the disease-causing Xanthamonas bacteria that are known to attack rice -- the staple food for half of the world's population -- as well as maize, cassava, sugar cane, tomatoes, peppers, wheat, alfalfa, onions, banana and citrus.
"Our research team is delighted to announce the discovery of the RaxX protein, a new class of microbial signaling molecules ," said Pamela Ronald, a professor in UC Davis' Department of Plant Pathology and Genome Center, who directed the study.
Ronald noted that her laboratory is currently investigating the role of RaxX during bacterial infection of rice in the absence of the immune receptor.
The researchers have noticed that RaxX closely resembles a class of plant signaling factors that promote growth and modulate the immune response. They suspect that the bacteria could be mimicking these natural plant-signaling factors to inhibit the plant immune response and thereby enhance the competitiveness of the bacteria.
In the long term, the researchers hope to use this information to develop new strategies to prevent infection in various crops.
New findings have special significance:
Publication of the new study is particularly poignant for Ronald and lead co-authors Rory Pruitt and Benjamin Schwessinger, because it brings the research team full circle in correcting unintentional errors that led the Ronald lab in 2009 to misidentify the protein now known to be RaxX.
Pruitt and Schwessinger both worked on the new study as postdoctoral scholars in the Ronald lab, and Schwessinger is now an independent research fellow at the Australian National University in Canberra, Australia.
Ronald's laboratory has been studying rice genetics and disease resistance for more than two decades and in 1995 announced that a gene called Xa21 confers resistance to the bacterial blight pathogen. Bacterial blight, one of the worst bacterial plant diseases in the world, has been found in virtually every crop species including rice.
The discovery of Xa21 was widely acclaimed by the scientific community and sparked further research into other key parts of the disease-resistance puzzle. Researchers were confident that if Xa21 produced a "receptor" in the plant cell that was capable of recognizing and thwarting a bacterial invasion, there must be a complementary protein in the bacteria that triggered that immune response in the plant.
In 2009 the Ronald lab announced discovery of a bacterial protein called Ax21, which their research indicated was the protein that triggers the immune response by the Xa21 plant receptor. A second related study, based on identification of Ax21, was published in 2011.
Then in 2013, as researchers in the Ronald lab began repeating the earlier experiments in preparation for a new study, they discovered that a bacterial strain had been mislabeled in the previous work and that one of the tests used in the earlier study turned out to be quite variable. These errors had led to the misidentification of Ax21 as the bacterial protein that sparks an immune response by the Xa21 receptor in the plant cells.
After finding the errors, Ronald retracted two papers from her laboratory about this research, published in 2009 and 2011 in the journals PLOS ONE and Science, respectively. She chronicled the story of that process in an October 2013 Scientific American blog posting titled, "Lab Life: The Anatomy of a Retraction," which can be found at http://bit.ly/1KdEDli.
INFORMATION:
Collaborators and funders:
Collaborating with Ronald, Schwessinger and Pruitt on the new study were researchers from UC Davis; Lawrence Berkeley National Laboratory; University of Tübingen, Germany; University of Texas at Austin; UC Irvine; and the Council of Scientific and Industrial Research, India.
Funding for the study was provided by the U.S. National Institutes of Health, the U.S. Department of Energy, the European Molecular Biology Association, the Human Frontiers Science Program, the Council of Scientific and Industrial Research in India, the Welch Foundation, and Monsanto's Beachell-Borlaug International Scholars Program.
Media contacts:
-- Rory Pruitt, UC Davis Plant Pathology Dept., (334) 294-7673, rory.pruitt@gmail.com
-- Pamela Ronald, UC Davis Plant Pathology Dept., (530) 219-4618, pcronald@ucdavis.edu
-- Benjamin Schwessinger, Australian National University, benjamin.schwessinger@gmail.com
-- Pat Bailey, UC Davis News Service, (530) 752-9843, pjbailey@ucdavis.edu
Grand Rapids, Michigan (July 24, 2015)--Scientists at Van Andel Research Institute (VARI) have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
In plants as in animals and humans, intricate molecular networks regulate key biological functions, such as development and stress responses. The system can be likened to a massive switchboard--when the wrong switches are flipped, genes can be inappropriately turned ...
ORLANDO, Fla. (July 21, 2015) - A new peer-reviewed study published in the Journal of Mammalogy by the Oxford University Press adds important insights to the debate over how long killer whales in human care live. The study found no difference in life expectancy between killer whales born at SeaWorld and a well-studied population of wild killer whales.
The study, "Comparisons of life-history parameters between free-ranging and captive killer whale (Orcinus orca) populations for application toward species management," compares current published data for survival and ...
You don't think you're hungry, then a friend mentions how hungry he is or you smell some freshly baked pizza and whoaaa, you suddenly feel really hungry. Or, you've had surgery and need a bit of morphine for pain. As soon as you hit that button you feel relief even though the medicine hasn't even hit your bloodstream.
These are two examples of the oft-studied placebo effect that demonstrate the amazing and still somewhat confounding powers of the human brain.
Now, CU-Boulder graduate student Scott Schafer, who works in Associate Professor Tor Wager's Cognitive and Affective ...
The health of Colorado's bighorn sheep population remains as precarious as the steep alpine terrain the animals inhabit, but a new study led by researchers at the University of Colorado Boulder has found that inbreeding--a common hypothesis for a recent decline--likely isn't to blame.
Bighorn herds tend to be small and isolated in their mountain ecosystems, putting the animals at high risk for a genetic "bottleneck," said Catherine Driscoll, a graduate student in the Department of Ecology and Evolutionary Biology at CU-Boulder and lead author of the study. Previous research ...
As well as the daily strain of their working lives, shift workers are probably also more likely than other people to develop cancer. While this has been well described for breast cancer, few studies had examined the correlation between shift work and prostate cancer. In a recent original article in Deutsches Ärzteblatt International (Dtsch Arztbl Int 112: 463-70), Gael P. Hammer et al. show that shift workers do not develop prostate cancer more frequently than their colleagues who work during the day.
Shift work is widespread: between approximately one in five and ...
CAMBRIDGE, Mass. -- John Leonard's group in the MIT Department of Mechanical Engineering specializes in SLAM, or simultaneous localization and mapping, the technique whereby mobile autonomous robots map their environments and determine their locations.
Last week, at the Robotics Science and Systems conference, members of Leonard's group presented a new paper demonstrating how SLAM can be used to improve object-recognition systems, which will be a vital component of future robots that have to manipulate the objects around them in arbitrary ways.
The system uses SLAM ...
This news release is available in Spanish.
Since 2006, the team of researchers has sequenced the mitochondrial DNA of all the known species of butterflies in the Iberian peninsula (228) and its main populations. The result is a report that compiles more than 3500 genetic sequences of all the species, which have been compared to the genetic sequences of other European populations. The paper has 277 pages of supplementary material, including pictures and 80 maps of the geographical distribution of the butterfly genetic lineages identified.
This is the first time ...
(Philadelphia, PA) - Patients who have lower extremity proximal deep vein thrombosis (LE-DVT), or a blood clot in their leg, are increasingly undergoing minimally invasive catheter-based blood clot removal - also referred to as catheter-directed thrombolysis (CDT) - rather than solely being treated with traditional blood-thinning medications (anticoagulation alone). This trend is due to recent literature showing reductions in lifestyle-limiting post-thrombotic complications of acute DVT in patients who undergo CDT compared to those that are treated with anticoagulation ...
This news release is available in German.
Pathogenic bacteria develop killer machines that work very specifically and highly efficiently. Scientists from the University of Freiburg have solved the molecular mechanism of a fish toxin that could be used in the future as a medication to treat cancer. The scientists have now published their research in the journal Nature Communications.
The Yersinia species of pathogens can cause the bubonic plague and serious gastrointestinal infections in humans. The pharmacologist Dr. Thomas Jank and his fellow researchers in the ...
La Jolla, Calif., July 23, 2015 - A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the lymphotoxin-beta receptor (LTβR), reduces the progression of liver cancer. The results, published today in the online edition of Gut, could provide new treatment strategies for the disease, which is the third leading cause of cancer-related deaths worldwide.
"Our findings point to a new way to improve the treatment ...
